Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
06/2003
06/11/2003EP1317417A2 2-amino-2-alkyl-3 heptenoic and heptynoic acid derivatives useful as nitric oxide synthase inhibitors
06/11/2003EP1317414A2 Gamma-ketoacid dipeptides as inhibitors of caspase-3
06/11/2003EP1317413A1 Substituted biphenyl derivatives, method for preparing same and pharmaceutical compositions containing same
06/11/2003EP1317411A1 Derivatives of naphthalene with comt inhibiting activity
06/11/2003EP1317306A2 Transdermal electrotransport device and method for manufacturing same
06/11/2003EP1317304A1 Slow release pharmaceutical preparation and method of administering same
06/11/2003EP1317285A1 Methods for treating demyelinating diseases
06/11/2003EP1317283A2 Tweak receptor agonists as anti-angiogenic agents
06/11/2003EP1317276A2 Therapeutic use of a recombinant erythropoietin having high activity and reduced side effects
06/11/2003EP1317273A1 Use of il-6r/il-6 chimera in huntington's disease
06/11/2003EP1317267A2 Compositions containing diacyltartaric salts of (e)-metanicotine
06/11/2003EP1317266A2 Neuroprotective 2-pyridinamine compositions and related methods
06/11/2003EP1317264A2 Combination of lipoic acids and conjugated acids for treating diabetic disorders
06/11/2003EP1317258A2 Use of agents capable of reducing uric acid levels for the treatment of cardiovascular disease
06/11/2003EP1060161B1 Matrix metalloproteinase inhibitors
06/11/2003EP1024810A4 Method for optimizing retinal and optic nerve health
06/11/2003EP1021413B1 The preparation and use of ortho-sulfonamido bicyclic heteroaryl hydroxamic acids as matrix metalloproteinase and tace inhibitors
06/11/2003EP1011683A4 Vitamin d analogues and their neuronal effects
06/11/2003EP0973741B1 S-2'-(2-(1-methyl-2-piperidyl) ethyl) cinnamanilide as a 5-ht2 receptor antagonist
06/11/2003EP0950053B1 New derivatives of benzoylalkyl-1,2,3,6-tetrahydropyridins
06/11/2003EP0539492B1 Antigenic iron repressible proteins from n. meningitidis related to the hemolysin family of toxins
06/11/2003CN1423700A Multifunctional polypeptides comprising a binding site to and epitope of the NKG2D receptor complex
06/11/2003CN1423658A Modulation of human sodium channels in dorsal root ganglia
06/11/2003CN1423657A Inter feron-alpha induced gene
06/11/2003CN1423651A New use and novel N-azabicyclo-amide derivatives
06/11/2003CN1423649A Sulfonyl oxazole amines and their use as 5-HT6 receptor ligand
06/11/2003CN1423646A Hetero cyclo-alkylsulfonyl pyrazole derivatives as anti-inflammatory/analgesic agents
06/11/2003CN1423645A 维他命d类似物 Vitamin d analogues
06/11/2003CN1423644A Method for the preparation of citalopram
06/11/2003CN1423633A Azetidine derivatives, preparation thereof and pharmaceutical compositions
06/11/2003CN1423559A Controlled-release compositions containing opioid agonist and antagonist
06/11/2003CN1423556A Transdermal or transmucosal dosage forms with a nicotine-containing active substance combination for smoker disintoxication
06/11/2003CN1422859A Reaction method of biological alkali, reaction product and use thereof
06/11/2003CN1422660A Chinese medicine for treating epilepsia and preparation method thereof
06/11/2003CN1111058C Vesania-treating medicine
06/11/2003CN1111045C Chewing medicine for treating facial paralysis and its preparing process
06/10/2003US6576793 β2-adrenergic receptor agonists
06/10/2003US6576791 Local anesthetic compounds and uses
06/10/2003US6576764 Reacting 2-aminopyridine compound with N-methyl-1-phenyl-2,2-iminodiethyl-chloride; cyclization
06/10/2003US6576762 Heteroaromatic substituted amides with antagonistic activity to neurokinin 1 receptors
06/10/2003US6576751 FADD-like anti-apoptotic molecules, methods of using the same, and compositions for and methods of making the same
06/10/2003US6576672 Parkingson's Disease and dementias characterized by mito-chondrial damage; such as 3,7-diazanonane-1,9-diamine; neutralizing dopamine depriving effect
06/10/2003US6576666 First fatty acid compound that is a linoleic or linolenic compound and a second fatty acid that is a docosahexaenoic acid compound, an omega-3 or an omega-2 fatty acid or derivative
06/10/2003US6576650 No central nervous system side effects
06/10/2003US6576648 Compound with growth hormone releasing properties
06/10/2003US6576646 Administering cholinesterase inhibitor
06/10/2003US6576645 Triphenylalkene derivatives and their use as selective estrogen receptor modulators
06/10/2003US6576641 For therapy and prophylaxis of Alzheimer's disease, Parkinson's disease, Huntington's disease, amyotrophic lateral sclerosis (ALS), or a neurodegenerative disease of the eye, including photoreceptor loss in retina
06/10/2003US6576640 Rapidly penetration into central nervous system; treating noradrenaline deficiency; depression, Parkinson's disease
06/10/2003US6576626 Treating gastro-oesophageal reflux disease
06/10/2003US6576268 Biologically active fraction of vegetable melanin, process for its production and its use
06/10/2003US6576260 Sustained-release form of administration containing tramadol saccharinate
06/10/2003US6576252 Composition providing calming, stress hormone regulating and immune stimulation effect, which comprises component including combination of linoleic and linolenic acids in specified ratio, and component taken from flavonoid group
06/10/2003CA2225156C Use of unsubstituted and substituted n-(pyrrol-1-yl)pyridinamines as anticonvulsant agents
06/10/2003CA2192354C Corticotropin releasing factor against antagonist
06/10/2003CA2133427C Enantiomeric 1-phenyl-2-(2-pyridinyl) ethylamine for the treatment of neurodegenerative disorders
06/10/2003CA2083505C New use of diphenylbutyl-piperazinecarboxamides in the treatment of substance disorders
06/10/2003CA2040489C 4-¬3-(4-oxothiazoldinyl)|butynylamines, a process for their preparation and their use as medicaments
06/06/2003CA2413479A1 Kit for reducing aching
06/05/2003WO2003046580A1 Assay for screening candidate drugs for the treatment of inflammatory diseases
06/05/2003WO2003046570A2 Glycoprotein and apolipoprotein biopolymer markers predictive of alzheimers disease
06/05/2003WO2003046569A1 Fibronectin precursor biopolymer marker predictive of alzheimers disease
06/05/2003WO2003046568A2 Protein biopolymer markers indicative of a disease state
06/05/2003WO2003046565A2 Ig lambda biopolymer markers predictive of alzheimers disease
06/05/2003WO2003046564A2 Protein biopolymer markers predictive of alzheimers disease
06/05/2003WO2003046552A2 Screening method for compounds that modulate neuronal activity
06/05/2003WO2003046172A2 Alzheimer’s disease model
06/05/2003WO2003046141A2 Methods for making and using reprogrammed human somatic cell nuclei and autologous and isogenic human stem cells
06/05/2003WO2003046135A2 Osteopontin-related compositions and methods
06/05/2003WO2003046012A1 Antigen presenting cell targeting conjugate, an antigen presenting cell contacted with such conjugate, their use for vaccination or as medicament, and methods for their production or generation
06/05/2003WO2003046011A1 Antigen presenting cell targeting conjugate an antigen presenting cell contacted with such conjugate their use for vaccination or as medicament and methods for their production or generation
06/05/2003WO2003046010A1 Inter alpha trypsin inhibitor biopolymer markers indicative of insulin resistance
06/05/2003WO2003046008A1 Therapeutic use of antibodies and fragments thereof binding primate ifn-gamma
06/05/2003WO2003045999A2 Human vanilloid receptor protein and polynucleotide sequence encoding same
06/05/2003WO2003045991A2 Complement c3 precursor biopolymer markers predictive of alzheimers disease
06/05/2003WO2003045978A2 Antagonist anti-cd40 monoclonal antibody therapy for multiple sclerosis treatment
06/05/2003WO2003045974A2 Methods and compositions for derepression of iap-inhibited caspase
06/05/2003WO2003045967A1 Aryl fused azapolycyclic compounds
06/05/2003WO2003045951A1 Triazolo[4,3-a]pyrido[2,3-d]pyrimidin-5-one derivatives, compositions containing same, preparation method and use thereof
06/05/2003WO2003045950A1 Pyrazolopyridine derivtives and their pharmaceutical use
06/05/2003WO2003045949A1 Pyrazolopyridine derivatives
06/05/2003WO2003045944A1 Aromatic sulfone hydroxamic acids and their use as protease inhibitors
06/05/2003WO2003045940A2 Benzazepine derivatives and their use as 5-ht ligands
06/05/2003WO2003045926A1 5-sulphanyl-4h-1,2,4-triazole derivatives and their use as medicine
06/05/2003WO2003045924A1 Substituted aryl 1,4-pyrazine derivatives
06/05/2003WO2003045923A1 Preventives or remedies for alzheimer’s disease or amyloid protein fibrosis inhibitors containing nitrogen-containing heteroaryl compounds
06/05/2003WO2003045922A1 Sulfone derivatives and their use in the treatment of autoimmune diseases and allergies
06/05/2003WO2003045920A1 4-aminoquinoline compounds
06/05/2003WO2003045918A1 Piperidine-based mch antagonists for treatment of obesity and cns disorders
06/05/2003WO2003045913A1 Benzamide derivatives, processes for their preparation, and their pharmaceutical use
06/05/2003WO2003045903A1 Hydroxyethylene compounds with asp2 inhibitory activity
06/05/2003WO2003045902A1 Branched chain amino acid-dependent aminotransferase inhibitors and their use in the treatment of neurodegenerative diseases
06/05/2003WO2003045898A1 Prodrugs of excitatory amino acids
06/05/2003WO2003045897A1 Neorologically-active compounds
06/05/2003WO2003045582A1 Metallic structures incorporating bioactive materials and methods for creating the same
06/05/2003WO2003045499A1 METHODS RELATED TO AN α4 NICOTINIC ACETYLCHOLINE RECEPTOR SUBUNIT MUTANT
06/05/2003WO2003045439A1 Genetic remedies for neurodegenerative diseases
06/05/2003WO2003045437A1 Pharmaceutical compositions of 5,7,14-triazatetracyclo[10.3.1.0(2,11).0(4,9)]-hexadeca-2(11)3,5,7,9-pentaene
06/05/2003WO2003045434A2 Endothelin antagonists ina method and composition for potentiating an opiate analgesic
06/05/2003WO2003045407A1 A pharmaceutical composition of chinese herbs for treating snuffle, headache and the use thereof
1 ... 1206 1207 1208 1209 1210 1211 1212 1213 1214 1215 1216 1217 1218 1219 1220 1221 1222 1223 1224 1225 1226 ... 1833